Recherche
-
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Dual Orexin Receptor Antagonists and Suicide Risk: Findings From the WHO Spontaneous Reporting Database
(Journal of Clinical Psychiatry. vol. 84, n° 6, 2023-09-27)Article de revue -
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
(Targeted Oncology. vol. 18, n° 5, pp. 717-726, 2023-09-01)Article de revue -
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
(Therapies, 2023-03-07)Article de revue -
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
(Therapies, 2023-03-11)Article de revue -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès